Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
暂无分享,去创建一个
J. Halter | A. Sinclair | I. Hirsch | G. Biessels | M. Murad | F. Casanueva | D. Leroith | B. Draznin | M. Molitch | S. Braithwaite | M. McDonnell
[1] C. Mathieu,et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2019, Diabetologia.
[2] David M Maahs,et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. , 2019, Diabetes technology & therapeutics.
[3] Deepak L. Bhatt,et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.
[4] 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[5] 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[6] 12. Older Adults: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[7] 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[8] 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[9] R. Collins,et al. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.
[10] Geltrude Mingrone,et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2018, Diabetes Care.
[11] M. Blaha,et al. Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention Guidelines , 2018, Current Treatment Options in Cardiovascular Medicine.
[12] Björn Eliasson,et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes , 2018, The New England journal of medicine.
[13] Alyson K. Myers,et al. Obesity, obstructive sleep apnea and type 2 diabetes mellitus: Epidemiology and pathophysiologic insights , 2018, Sleep medicine and disorders : international journal.
[14] M. Conaway,et al. Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy , 2018, Neurology.
[15] Wilbert S Aronow,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.
[16] J. Williamson,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.
[17] Amber D. Seelig,et al. Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study , 2018, Diabetes Care.
[18] D. Reda,et al. Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT) , 2018, Diabetologia.
[19] Karla I. Galaviz,et al. Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials , 2017, JAMA internal medicine.
[20] M. Bernstein. Nutritional Needs of the Older Adult. , 2017, Physical medicine and rehabilitation clinics of North America.
[21] N. H. Ismail,et al. Assessing the nutritional status of hospitalized elderly , 2017, Clinical interventions in aging.
[22] Dave L Dixon,et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP , 2017, Diabetes Care.
[23] J. Logomarsino,et al. Evaluating the effectiveness of five screening tools used to identify malnutrition risk in hospitalized elderly: A systematic review , 2017, Geriatric nursing.
[24] A. Sinclair,et al. Frailty and sarcopenia - newly emerging and high impact complications of diabetes. , 2017, Journal of diabetes and its complications.
[25] I. D. de Boer,et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.
[26] K. Fujisue,et al. Current status of lipid management in acute coronary syndrome. , 2017, Journal of cardiology.
[27] D. Armstrong,et al. Diabetic Foot Ulcers and Their Recurrence. , 2017, The New England journal of medicine.
[28] D. Armstrong,et al. Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S. , 2017, Diabetes Care.
[29] K. Mahaffey,et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.
[30] B. Zinman,et al. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes , 2017, The New England journal of medicine.
[31] A. Chaudhary,et al. Acute Pancreatitis Secondary to Severe Hypertriglyceridemia: Management of Severe Hypertriglyceridemia in Emergency Setting , 2017, Gastroenterology research.
[32] Ju Han Kim,et al. Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients. , 2017, International journal of cardiology.
[33] D. Mark,et al. Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial) , 2017, Circulation. Cardiovascular quality and outcomes.
[34] K. Ruedy,et al. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial , 2017, Journal of diabetes science and technology.
[35] Eliot A Brinton,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[36] Nadeem Shafique Butt,et al. Effect of diet on type 2 diabetes mellitus: A review , 2017, International journal of health sciences.
[37] T. Wilt,et al. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians , 2017, Annals of Internal Medicine.
[38] J. Halter,et al. The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations , 2017, Diabetes Care.
[39] G. Umpierrez,et al. Management of Inpatient Hyperglycemia and Diabetes in Older Adults , 2017, Diabetes Care.
[40] D. Giugliano,et al. Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials , 2017, Diabetes Care.
[41] M. Barry,et al. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. , 2017, Annals of internal medicine.
[42] Jennifer K. Sun,et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.
[43] Yu Gu,et al. Are falls prevention programs effective at reducing the risk factors for falls in people with type-2 diabetes mellitus and peripheral neuropathy: A systematic review with narrative synthesis. , 2017, Journal of diabetes and its complications.
[44] L. Kappelle,et al. Chronic hyperglycemia is related to poor functional outcome after acute ischemic stroke , 2017, International journal of stroke : official journal of the International Stroke Society.
[45] Jing-Shiang Hwang,et al. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study. , 2017, International journal of cardiology.
[46] D. Kansagara,et al. Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older , 2017, Annals of Internal Medicine.
[47] M. Signy,et al. Ezetimibe: an update on its clinical usefulness in specific patient groups , 2017, Therapeutic advances in chronic disease.
[48] Jonathan E. Brown,et al. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. , 2016, Diabetes & metabolism.
[49] D. Dunstan,et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association , 2016, Diabetes Care.
[50] J. Potter,et al. Which Frail Older People Are Dehydrated? The UK DRIE Study. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.
[51] E. Koo,et al. The Utility of Brief Cognitive Tests for Patients With Type 2 Diabetes Mellitus: A Systematic Review. , 2016, Journal of the American Medical Directors Association.
[52] C. O'connor,et al. A Comprehensive Review of the Literature Supporting Recommendations From the Canadian Diabetes Association for the Use of a Plant-Based Diet for Management of Type 2 Diabetes. , 2016, Canadian journal of diabetes.
[53] B. Draznin,et al. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[54] A. Ades,et al. Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes-Network meta-analysis of randomized trials. , 2016, Journal of diabetes and its complications.
[55] Svetlana K. Eden,et al. The diabetes nutrition education study randomized controlled trial: A comparative effectiveness study of approaches to nutrition in diabetes self-management education. , 2016, Patient education and counseling.
[56] F. Schmitt,et al. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.
[57] A. Solini,et al. What Should Be the Target Blood Pressure in Elderly Patients With Diabetes? , 2016, Diabetes Care.
[58] R. DeFronzo,et al. Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment Algorithm , 2016, Diabetes Care.
[59] John M Lachin,et al. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. , 2016, The New England journal of medicine.
[60] J. Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.
[61] D. Goff,et al. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study , 2016, Diabetes Care.
[62] G. Bakris,et al. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What’s the Fuss? , 2016, Diabetes Care.
[63] J. Rosenstock,et al. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial , 2016, Diabetes Care.
[64] Ryan T. Crews,et al. Role and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation , 2016, Diabetes Care.
[65] Naveed Sattar,et al. The changing face of diabetes complications. , 2016, The lancet. Diabetes & endocrinology.
[66] L. Kappelle,et al. Case‐finding for cognitive impairment among people with Type 2 diabetes in primary care using the Test Your Memory and Self‐Administered Gerocognitive Examination questionnaires: the Cog‐ID study , 2016, Diabetic medicine : a journal of the British Diabetic Association.
[67] R. Gilbert,et al. Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies. , 2016, Canadian journal of diabetes.
[68] J. Manson,et al. Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women , 2016, European Journal of Epidemiology.
[69] G. Mancia,et al. Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials , 2016, Hypertension.
[70] V. Perkovic,et al. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. , 2016, The lancet. Diabetes & endocrinology.
[71] C. Shin,et al. Risk of fractures and diabetes medications: a nationwide cohort study , 2016, Osteoporosis International.
[72] A. Vinik. CLINICAL PRACTICE. Diabetic Sensory and Motor Neuropathy. , 2016, The New England journal of medicine.
[73] Laura G. Qualls,et al. TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[74] S. Yusuf,et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.
[75] J. Manson,et al. Multiple Healthful Dietary Patterns and Type 2 Diabetes in the Women's Health Initiative. , 2016, American journal of epidemiology.
[76] R. Varma,et al. Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010). , 2016, Ophthalmic surgery, lasers & imaging retina.
[77] B. Timar,et al. Age as an independent factor for the development of neuropathy in diabetic patients , 2016, Clinical interventions in aging.
[78] Sei J. Lee,et al. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. , 2016, JAMA.
[79] A. Sinclair,et al. Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis , 2016, Journal of the American Geriatrics Society.
[80] B. Davis,et al. Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses , 2016, PLoS medicine.
[81] P. Katzmarzyk,et al. Blood pressure and all-cause mortality among patients with type 2 diabetes. , 2016, International journal of cardiology.
[82] B. Carlberg,et al. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses , 2016, British Medical Journal.
[83] G. Bray,et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. , 2016, The Journal of clinical endocrinology and metabolism.
[84] C. Mathieu,et al. Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort Study. , 2016, The Journal of clinical endocrinology and metabolism.
[85] U. Iloeje,et al. ASSOCIATION BETWEEN HYPOGLYCEMIA AND FALL-RELATED FRACTURES AND HEALTH CARE UTILIZATION IN OLDER VETERANS WITH TYPE 2 DIABETES. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[86] M. Woodward,et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.
[87] W. Cushman,et al. Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes , 2016, Diabetes Care.
[88] K. Khunti,et al. Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments , 2016, Annals of Internal Medicine.
[89] Tracey H. Taveira,et al. Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association , 2016, Diabetes Care.
[90] Irl B Hirsch,et al. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[91] M. Foster,et al. Type 2 diabetes–related foot care knowledge and foot self-care practice interventions in the United States: a systematic review of the literature , 2016, Diabetic foot & ankle.
[92] S. Bus,et al. Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review , 2016, Diabetes/metabolism research and reviews.
[93] R. Beck,et al. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes , 2015, Diabetes Care.
[94] P. Guarino,et al. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[95] S. Solomon,et al. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. , 2015, The New England journal of medicine.
[96] B. Zinman,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.
[97] J. Morley,et al. Rapid screening for sarcopenia , 2015, Journal of cachexia, sarcopenia and muscle.
[98] N. Freemantle,et al. IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy , 2015, Diabetes Therapy.
[99] L. Chuang,et al. Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study , 2015, Diabetic medicine : a journal of the British Diabetic Association.
[100] Jennifer G. Robinson,et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.
[101] P. Remington,et al. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force , 2015, Annals of Internal Medicine.
[102] E. Barrett-Connor,et al. Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study , 2015, The lancet. Diabetes & endocrinology.
[103] Deepak L. Bhatt,et al. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry , 2015, Circulation.
[104] L. Geiss,et al. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.
[105] A. García-de-Lorenzo,et al. PREDyCES study: The cost of hospital malnutrition in Spain. , 2015, Nutrition.
[106] D. Klonoff,et al. PRIDE Statement on the Need for a Moratorium on the CMS Plan to Cite Hospitals for Performing Point-of-Care Capillary Blood Glucose Monitoring on Critically Ill Patients. , 2015, The Journal of clinical endocrinology and metabolism.
[107] G. Umpierrez,et al. A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities , 2015, BMJ Open Diabetes Research and Care.
[108] D. Margolis,et al. Diabetes, Lower-Extremity Amputation, and Death , 2015, Diabetes Care.
[109] G. Meininger,et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program , 2015, Diabetes Care.
[110] M. Pencina,et al. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. , 2015, The New England journal of medicine.
[111] G. Umpierrez,et al. BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[112] C. Mazzucchelli,et al. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–149 , 2015, Diabetes Care.
[113] I. Hirsch,et al. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition , 2015, Diabetes Care.
[114] Mark E. Molitch,et al. Management of diabetes mellitus in patients with chronic kidney disease , 2015, Clinical Diabetes and Endocrinology.
[115] D. Reda,et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. , 2015, The New England journal of medicine.
[116] Nataliya Shinkazh,et al. Pharmacological treatment of diabetic peripheral neuropathy. , 2015, P & T : a peer-reviewed journal for formulary management.
[117] H. Krum,et al. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy , 2015, The Lancet.
[118] Kamlesh Khunti,et al. Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) , 2015, Diabetes Care.
[119] David M Maahs,et al. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry , 2015, Diabetes Care.
[120] G. Guyatt,et al. Guideline panels should not GRADE good practice statements. , 2015, Journal of clinical epidemiology.
[121] Deepak L. Bhatt,et al. Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials. , 2015, The lancet. Diabetes & endocrinology.
[122] G. Bakris,et al. Update on Blood Pressure Goals in Diabetes Mellitus , 2015, Current Cardiology Reports.
[123] Jennifer G. Robinson,et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.
[124] A. Sinclair,et al. Diabetes in older people: new insights and remaining challenges. , 2015, The lancet. Diabetes & endocrinology.
[125] Jennifer K. Sun,et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. , 2015, The New England journal of medicine.
[126] M. Maguire,et al. Treatment choice for diabetic macular edema. , 2015, The New England journal of medicine.
[127] Steven J. Brown,et al. Diabetic Peripheral Neuropathy Compromises Balance During Daily Activities , 2015, Diabetes Care.
[128] Sei J. Lee,et al. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. , 2015, JAMA internal medicine.
[129] F. Sloan,et al. Causes of the Change in the Rates of Mortality and Severe Complications of Diabetes Mellitus: 1992–2012 , 2015, Medical care.
[130] C. Lyketsos,et al. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. , 2015, The American journal of psychiatry.
[131] K. Rahimi,et al. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.
[132] Lee Hooper,et al. Increasing fluid intake and reducing dehydration risk in older people living in long-term care: a systematic review. , 2015, Journal of the American Medical Directors Association.
[133] H. Keller,et al. Improving food and fluid intake for older adults living in long-term care: a research agenda. , 2015, Journal of the American Medical Directors Association.
[134] B. Hawkins,et al. Blood pressure control for diabetic retinopathy. , 2015, The Cochrane database of systematic reviews.
[135] H. Sørensen,et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study , 2015, Diabetes Care.
[136] R. MacIsaac,et al. Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: an analysis of intervention trials , 2015, Journal of Human Hypertension.
[137] B. Zinman,et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. , 2015, JAMA.
[138] Silvio E. Inzucchi,et al. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. , 2014, JAMA.
[139] R. Gómez-Huelgas,et al. Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine , 2014, BMC Cardiovascular Disorders.
[140] D. Matthews,et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.
[141] Walter T Ambrosius,et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. , 2014, Ophthalmology.
[142] Michael E. Miller,et al. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial , 2014, The Lancet.
[143] N. Bressler,et al. Prevalence of and risk factors for diabetic macular edema in the United States. , 2014, JAMA ophthalmology.
[144] Yun-fa Jiang,et al. Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. , 2014, Bone.
[145] M. Malone,et al. The effect of diabetes mellitus on costs and length of stay in patients with peripheral arterial disease undergoing vascular surgery. , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[146] G. Biolo,et al. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. , 2014, Clinical nutrition.
[147] I. D. de Boer,et al. Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.
[148] A. Sinclair,et al. Diabetes and dementia in older people: a Best Clinical Practice Statement by a multidisciplinary National Expert Working Group , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[149] G. Umpierrez,et al. Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes , 2014, Diabetes Care.
[150] M. Martinez-Alonso,et al. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications , 2014, Health and Quality of Life Outcomes.
[151] D. Blazer,et al. Substance abuse among older adults. , 2014, Clinics in geriatric medicine.
[152] X. Wan,et al. Meta-analysis of the risk of cataract in type 2 diabetes , 2014, BMC Ophthalmology.
[153] G. Bakris,et al. Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy , 2014, American Journal of Nephrology.
[154] Desmond E. Williams,et al. Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.
[155] Kevin P. High,et al. Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions , 2014, Diabetes.
[156] E. Rivero-Ferrer,et al. Incidence of Retinal Complications in a Cohort of Newly Diagnosed Diabetic Patients , 2014, PloS one.
[157] D. Sacks,et al. Interpretation of hemoglobin A1c values. , 2014, JAMA.
[158] M. Molitch,et al. Insulin therapy for type 2 diabetes mellitus. , 2014, JAMA.
[159] F. Hu,et al. Prevention and management of type 2 diabetes: dietary components and nutritional strategies , 2014, The Lancet.
[160] Virginia A. Moyer. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. , 2014, Annals of internal medicine.
[161] R. Kruse,et al. Impact of amputation level and comorbidities on functional status of nursing home residents after lower extremity amputation. , 2014, Journal of vascular surgery.
[162] T. Mueller,et al. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. , 2014, Journal of vascular surgery.
[163] Xuelin He,et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. , 2014, JAMA internal medicine.
[164] Desmond E. Williams,et al. Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.
[165] G. Guyatt,et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies , 2014, BMJ : British Medical Journal.
[166] Jose M Garcia,et al. Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review , 2014, Gerontology.
[167] J. Núñez,et al. Prognostic value of admission glycated haemoglobin in unknown diabetic patients with acute myocardial infarction , 2014, European heart journal. Acute cardiovascular care.
[168] L. Hooper,et al. Water-loss dehydration and aging , 2014, Mechanisms of Ageing and Development.
[169] Howard G. Birnbaum,et al. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers , 2014, Diabetes Care.
[170] G. Bakris,et al. Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga , 2014, Diabetes Care.
[171] Arlene Smaldone,et al. Diabetes Self-Care and the Older Adult , 2014, Western journal of nursing research.
[172] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[173] S. Colagiuri,et al. Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. , 2014, The lancet. Diabetes & endocrinology.
[174] Jennifer Y. Liu,et al. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. , 2014, JAMA internal medicine.
[175] A. Schwartz,et al. Eight-Year Weight Losses with an Intensive Lifestyle Intervention: The Look AHEAD Study , 2014, Obesity.
[176] L. Aiello. Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.
[177] J. Meyers,et al. Burden of Sliding Scale Insulin Use in Elderly Long‐Term Care Residents with Type 2 Diabetes Mellitus , 2013, Journal of the American Geriatrics Society.
[178] A. Keech,et al. An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes , 2013, Diabetes.
[179] P. Peduzzi,et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.
[180] Elizabeth Eckstrom,et al. Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.
[181] G. Umpierrez,et al. Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study. , 2013, Journal of the American Medical Directors Association.
[182] José Agustín Arguedas,et al. Blood pressure targets for hypertension in people with diabetes mellitus. , 2013, The Cochrane database of systematic reviews.
[183] Wei-Chih Liao,et al. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis , 2013, BMJ.
[184] S. Heymsfield,et al. HbA1c and Lower-Extremity Amputation Risk in Low-Income Patients With Diabetes , 2013, Diabetes Care.
[185] Craig Wilson,et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. , 2013, The New England journal of medicine.
[186] Deepak L. Bhatt,et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.
[187] J M Sparrow,et al. United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services , 2013, Eye.
[188] H. Comber,et al. Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) , 2013, PloS one.
[189] A. Philis-Tsimikas. Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control. , 2013, The American journal of medicine.
[190] J. Stein,et al. Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. , 2013, Ophthalmology.
[191] B. Frier,et al. Diabetes and driving , 2013, Diabetes, obesity & metabolism.
[192] C. Attinger,et al. Inpatient Management of Diabetic Foot Disorders: A Clinical Guide , 2013, Diabetes Care.
[193] E. Simonsick,et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. , 2013, JAMA internal medicine.
[194] David R. Sinacore,et al. Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial , 2013, International Journal of Obesity.
[195] R. Beck,et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. , 2013, The Journal of clinical endocrinology and metabolism.
[196] S. Heymsfield,et al. Aggressive Blood Pressure Control Increases Coronary Heart Disease Risk Among Diabetic Patients , 2013, Diabetes Care.
[197] P. Kearney,et al. Does contact with a podiatrist prevent the occurrence of a lower extremity amputation in people with diabetes? A systematic review and meta-analysis , 2013, BMJ Open.
[198] Paul P. Lee,et al. TEN-YEAR INCIDENCE OF AGE-RELATED MACULAR DEGENERATION ACCORDING TO DIABETIC RETINOPATHY CLASSIFICATION AMONG MEDICARE BENEFICIARIES , 2013, Retina.
[199] A. Bhansali,et al. Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies , 2013, Journal of diabetes investigation.
[200] A. Turchin,et al. Hypoglycemia, With or Without Insulin Therapy, Is Associated With Increased Mortality Among Hospitalized Patients , 2013, Diabetes Care.
[201] M. Marre,et al. Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency , 2013, Diabetes Care.
[202] G. Umpierrez,et al. Contributions of Basal and Prandial Hyperglycemia to Total Hyperglycemia in Older and Younger Adults with Type 2 Diabetes Mellitus , 2013, Journal of The American Geriatrics Society.
[203] B. Draznin,et al. Practical Approach to Management of Inpatient Hyperglycemia in Select Patient Populations , 2013, Hospital practice.
[204] Daniala L. Weir,et al. Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure: Systematic Review of Observational Studies Involving 34 000 Patients , 2013, Circulation. Heart failure.
[205] C. Cook,et al. Trends in glycemic control over a 2-year period in 126 US hospitals. , 2013, Journal of hospital medicine.
[206] M. Stellefson,et al. The Chronic Care Model and Diabetes Management in US Primary Care Settings: A Systematic Review , 2013, Preventing chronic disease.
[207] Limin Peng,et al. Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes , 2013, Diabetes Care.
[208] Sai V. Yalla,et al. A Growing Troubling Triad: Diabetes, Aging, and Falls , 2013, Journal of aging research.
[209] A. Wimo,et al. The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.
[210] Nathaniel Clark,et al. Diabetes in Older Adults: A Consensus Report , 2012, Journal of the American Geriatrics Society.
[211] M. Kabeto,et al. Clinical complexity and mortality in middle-aged and older adults with diabetes. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[212] B. Frier,et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs , 2012, Diabetes, obesity & metabolism.
[213] Nathaniel Clark,et al. Diabetes in Older Adults , 2012, Diabetes Care.
[214] Thomas J. Songer,et al. Improvements in the Life Expectancy of Type 1 Diabetes , 2012, Diabetes.
[215] Lawrence A Leiter,et al. Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. , 2012, Archives of internal medicine.
[216] N. Skolnik,et al. Management of Hyperglycemia in Type 2 Diabetes , 2012 .
[217] Jennifer Y. Liu,et al. Symptom Burden of Adults with Type 2 Diabetes Across the Disease Course: Diabetes & Aging Study , 2012, Journal of General Internal Medicine.
[218] Salim Yusuf,et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. , 2012, The New England journal of medicine.
[219] C. Conner,et al. Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes , 2012, Diabetes, obesity & metabolism.
[220] E. Vittinghoff,et al. Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial , 2012, Diabetes Care.
[221] J. Wylie-Rosett,et al. Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010 (Diabetes Care (2012) 35, (434-445)) , 2012 .
[222] F. Rutten,et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes , 2012, Diabetologia.
[223] P. Lips,et al. Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. , 2012, Age and ageing.
[224] C. Huang,et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies , 2012, Internal medicine journal.
[225] A. Milne,et al. Measuring Health-Related Quality of Life for Patients with Diabetic Retinopathy , 2012 .
[226] Quan Dong Nguyen,et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. , 2012, Ophthalmology.
[227] D. Sultzer,et al. The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes , 2012, Journal of Behavioral Medicine.
[228] P. Emery,et al. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. , 2012, Journal of the National Cancer Institute.
[229] G. Umpierrez,et al. Insulin therapy for the management of hyperglycemia in hospitalized patients. , 2012, Endocrinology and metabolism clinics of North America.
[230] Michael E. Miller,et al. Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes , 2012, Diabetes Care.
[231] Paul Shekelle,et al. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians , 2012, Annals of Internal Medicine.
[232] Adam Drewnowski,et al. A conflict between nutritionally adequate diets and meeting the 2010 dietary guidelines for sodium. , 2012, American journal of preventive medicine.
[233] G. Reboldi,et al. Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes , 2012, Current Cardiology Reports.
[234] K. Pesudovs,et al. The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project , 2012, Quality of Life Research.
[235] J. Wylie-Rosett,et al. Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes , 2012, Diabetes Care.
[236] A. Chang,et al. Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis , 2012, Journal of the American Geriatrics Society.
[237] B. Chaitman,et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.
[238] Stephanie J. Fonda,et al. Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes , 2011, Diabetes Care.
[239] F. W. Germino. Noninsulin treatment of type 2 diabetes mellitus in geriatric patients: a review. , 2011, Clinical therapeutics.
[240] J. Zonszein,et al. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. , 2011, The American journal of medicine.
[241] N. Bressler,et al. Panretinal photocoagulation for proliferative diabetic retinopathy. , 2011, The New England journal of medicine.
[242] A. Vinik,et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management , 2011, Diabetes/metabolism research and reviews.
[243] Charles E. Leonard,et al. Location, Location, Location: Geographic Clustering of Lower-Extremity Amputation Among Medicare Beneficiaries With Diabetes , 2011, Diabetes Care.
[244] J. Birkmeyer,et al. Racial disparities in the use of revascularization before leg amputation in Medicare patients. , 2011, Journal of vascular surgery.
[245] B. Stuart,et al. Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. , 2011, The American journal of geriatric pharmacotherapy.
[246] Jennifer Y. Liu,et al. Correlates of Quality of Life in Older Adults With Diabetes , 2011, Diabetes Care.
[247] Xiaowu Sun,et al. Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection , 2011, Diabetes Care.
[248] P. Dodson,et al. Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies , 2011, Eye.
[249] Avan Aihie Sayer,et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. , 2011, Age and ageing.
[250] V. Gudnason,et al. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study , 2011, BMJ Open.
[251] Patrick J Heagerty,et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.
[252] S. Bangalore,et al. Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials , 2011, Circulation.
[253] T. Elgzyri,et al. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. , 2011, Journal of vascular surgery.
[254] Jennifer Y. Liu,et al. Glycemic Control, Complications, and Death in Older Diabetic Patients , 2011, Diabetes Care.
[255] R. Hermida,et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes , 2011, Diabetes Care.
[256] Å. Lernmark,et al. Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus , 2011, Diabetes Care.
[257] C. Cook,et al. Update on inpatient glycemic control in hospitals in the United States. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[258] J. Davidson,et al. Mild renal impairment and the efficacy and safety of liraglutide. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[259] G. Reboldi,et al. Diuretic Treatment of Hypertension , 2011, Diabetes Care.
[260] Francesco Bandello,et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.
[261] G. Guyatt,et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.
[262] Jennifer K. Sun,et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. , 2011, Ophthalmology.
[263] Donald R. Miller,et al. Trends in Initial Lower Extremity Amputation Rates Among Veterans Health Administration Health Care System Users From 2000 to 2004 , 2011, Diabetes Care.
[264] N. Marchionni,et al. Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials , 2011, Diabetes, obesity & metabolism.
[265] G. Biessels,et al. COGNITION IN OLDER PATIENTS WITH TYPE 1 DIABETES MELLITUS: A LONGITUDINAL STUDY , 2011, Journal of the American Geriatrics Society.
[266] Medha N Munshi,et al. Frequent hypoglycemia among elderly patients with poor glycemic control. , 2011, Archives of internal medicine.
[267] Jerry L. Grenard,et al. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. , 2011, The American journal of geriatric pharmacotherapy.
[268] Limin Peng,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.
[269] M. Cesari. Role of gait speed in the assessment of older patients. , 2011, JAMA.
[270] M. Tinetti,et al. Summary of the Updated American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons , 2011, Journal of the American Geriatrics Society.
[271] Robert J. Anderson,et al. Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial , 2010, Diabetes Care.
[272] Mark Woodward,et al. Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.
[273] R. Freeman,et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.
[274] T. Aspray,et al. Diabetes, falls and fractures. , 2010, Age and ageing.
[275] Rodica Pop-Busui,et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.
[276] R. Klein,et al. Are Individuals With Diabetes Seeing Better? , 2010, Diabetes.
[277] Walter T Ambrosius,et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.
[278] G. Bakris,et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.
[279] L. Ferrucci,et al. Nutritional recommendations for the management of sarcopenia. , 2010, Journal of the American Medical Directors Association.
[280] Lukasz Januszkiewicz. [The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus]. , 2010, Kardiologia polska.
[281] Mary Cushman,et al. Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.
[282] N. Wenger,et al. Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients , 2010, Current gerontology and geriatrics research.
[283] D. Mozaffarian,et al. Diabetes and coronary heart disease as risk factors for mortality in older adults. , 2010, The American journal of medicine.
[284] P. Wilson,et al. Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.
[285] J. Coresh,et al. The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study , 2010, Diabetes.
[286] W. Ambrosius,et al. Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial , 2010, Diabetes Care.
[287] John B Buse,et al. Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.
[288] J. Baeyens,et al. Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.
[289] G. Bakris,et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial , 2010, The Lancet.
[290] R. DeFronzo. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 , 2010, Diabetologia.
[291] K. Langa,et al. Clinical Complexity in Middle-Aged and Older Adults With Diabetes: The Health and Retirement Study , 2010, Medical care.
[292] H. Berlie,et al. Diabetes Medications Related to an Increased Risk of Falls and Fall-Related Morbidity in the Elderly , 2010, The Annals of pharmacotherapy.
[293] R. Heine,et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study , 2010, The Lancet.
[294] C. MacGilchrist,et al. Lower‐limb risk factors for falls in people with diabetes mellitus , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[295] E. Margaret Warton,et al. The Association Between the Number of Prescription Medications and Incident Falls in a Multi-ethnic Population of Adult Type-2 Diabetes Patients: The Diabetes and Aging Study , 2010, Journal of General Internal Medicine.
[296] Sheri R. Colberg,et al. Balance Training Reduces Falls Risk in Older Individuals With Type 2 Diabetes , 2010, Diabetes Care.
[297] Michael E. Miller,et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.
[298] D. Meier,et al. Palliative Care in the Treatment of Advanced Heart Failure , 2009, Circulation.
[299] M. Moser,et al. Use of diuretics in patients with hypertension. , 2009, The New England journal of medicine.
[300] K. Aminian,et al. The gait and balance of patients with diabetes can be improved: a randomised controlled trial , 2009, Diabetologia.
[301] David M Nathan,et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.
[302] A. Schols,et al. Muscle atrophy in cachexia: can dietary protein tip the balance? , 2009, Current opinion in clinical nutrition and metabolic care.
[303] A. Farmer,et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. , 2009, The New England journal of medicine.
[304] Todd A. Lee,et al. Lower-Extremity Amputation Risk After Charcot Arthropathy and Diabetic Foot Ulcer , 2009, Diabetes Care.
[305] David Kerr,et al. Diabetes Interactive Diary: A New Telemedicine System Enabling Flexible Diet and Insulin Therapy While Improving Quality of Life , 2009, Diabetes Care.
[306] K. Aminian,et al. Clinical factors associated with gait alterations in diabetic patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[307] D. Giugliano,et al. Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes , 2009, Annals of Internal Medicine.
[308] R. Heuberger. Alcohol and the Older Adult: A Comprehensive Review , 2009, Journal of nutrition for the elderly.
[309] M. Woodward,et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial , 2009, Diabetologia.
[310] Paul P. Lee,et al. Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression. , 2009, Ophthalmology.
[311] G. Cherr,et al. Superior limb salvage with endovascular therapy in octogenarians with critical limb ischemia. , 2009, Journal of vascular surgery.
[312] Samy Suissa,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[313] Mark V. Williams,et al. Transitions of Care Consensus policy statement: American College of Physicians, Society of General Internal Medicine, Society of Hospital Medicine, American Geriatrics Society, American College Of Emergency Physicians, and Society for Academic Emergency Medicine. , 2009, Journal of hospital medicine.
[314] E. Maltezos,et al. Risk Factors for Ipsilateral Reamputation in Patients with Diabetic Foot Lesions , 2009, The international journal of lower extremity wounds.
[315] M. Zhan,et al. Frequency of hypoglycemia and its significance in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[316] D. De Bacquer,et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. , 2009, Diabetes & metabolism.
[317] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[318] R. Townsend,et al. Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes. , 2009, Clinics in geriatric medicine.
[319] H. Krumholz,et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.
[320] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.
[321] J. Kushner,et al. Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age , 2009, Diabetes.
[322] A. Holstein,et al. Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions , 2009, Expert opinion on drug metabolism & toxicology.
[323] Nerrolyn Ramstrand,et al. Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population , 2009, Diabetes Care.
[324] G. Bakris,et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.
[325] G. Gensini,et al. Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials , 2008, Diabetes, obesity & metabolism.
[326] D. Belsky,et al. Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. , 2008, Archives of ophthalmology.
[327] Ronald Klein,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.
[328] U. Sambamoorthi,et al. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. , 2008, Journal of the American Medical Directors Association.
[329] H. Parving,et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.
[330] H. Parving,et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.
[331] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[332] Y. Gustafson,et al. Lower Systolic Blood Pressure Is Associated with Greater Mortality in People Aged 85 and Older , 2008, Journal of the American Geriatrics Society.
[333] O. Johansen,et al. Exenatide may aggravate moderate diabetic renal impairment: a case report. , 2008, British journal of clinical pharmacology.
[334] A. Vinik,et al. Diabetic neuropathy in older adults. , 2008, Clinics in geriatric medicine.
[335] M. Chin,et al. The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis , 2008, Annals of Internal Medicine.
[336] D. Margolis,et al. Association Between Renal Failure and Foot Ulcer or Lower-Extremity Amputation in Patients With Diabetes , 2008, Diabetes Care.
[337] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[338] W. Paulus,et al. Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study. , 2008, The Netherlands journal of medicine.
[339] H. Woerle,et al. Effect of Aging on Glucose Homeostasis , 2008, Diabetes Care.
[340] Tamara B. Harris,et al. Diabetes-related complications, glycemic control, and falls in older adults , 2008 .
[341] Sally Kerry,et al. Risk Factors for Fractures and Falls in Older Women with Type 2 Diabetes Mellitus , 2008, Calcified Tissue International.
[342] I. Baumgartner,et al. Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. , 2007, Journal of vascular surgery.
[343] Paul Cook,et al. The Relationship Between Glycemic Control and Falls in Older Adults , 2007, Journal of the American Geriatrics Society.
[344] P. Mitchell,et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.
[345] R. Nesto,et al. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials , 2007, The Lancet.
[346] Anushka Patel,et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.
[347] K. Wolski,et al. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.
[348] J. McMurray,et al. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. , 2007, Journal of the American College of Cardiology.
[349] P. Kothare,et al. Effect of renal impairment on the pharmacokinetics of exenatide , 2007, British journal of clinical pharmacology.
[350] D. Medeiros,et al. Dietary Reference Intakes: the Essential Guide to Nutrient Requirements edited by JJ Otten, JP Hellwig, and LD Meyers, 2006, 560 pages, hardcover, $44.96. The National Academies Press, Washington, DC. , 2007 .
[351] Richard W. Grant,et al. Prevalence of Hyper- and Hypoglycemia Among Inpatients With Diabetes , 2007, Diabetes Care.
[352] A. Vinik,et al. Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.
[353] Luigi Ferrucci,et al. Frailty: an emerging research and clinical paradigm--issues and controversies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[354] J. Lindström,et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.
[355] G. Hitman,et al. Analysis of Efficacy and Safety in Patients Aged 65–75 Years at Randomization , 2006, Diabetes Care.
[356] K. Ligon,et al. p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.
[357] James P. Boyle,et al. Impact of Recent Increase in Incidence on Future Diabetes Burden , 2006, Diabetes Care.
[358] Kathrin Maedler,et al. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. , 2006, Diabetes.
[359] A. Chang,et al. Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance , 2006 .
[360] L. Goldstein,et al. High-dose atorvastatin after stroke or transient ischemic attack. , 2006 .
[361] W. Willett,et al. Prospective Study of Diabetes and Risk of Hip Fracture , 2006, Diabetes Care.
[362] J. Hsia,et al. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes , 2006, Diabetes Care.
[363] P. Scheltens,et al. Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.
[364] Erland Erdmann,et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.
[365] L. Lavery,et al. Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. , 2005, Diabetes research and clinical practice.
[366] E. Lewis,et al. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. , 2005, Journal of the American Society of Nephrology : JASN.
[367] M. Maurer,et al. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[368] J. Kushner,et al. Very Slow Turnover of β-Cells in Aged Adult Mice , 2005 .
[369] I. McDowell,et al. A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.
[370] Ray Burke,et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. , 2005, Diabetes care.
[371] H. Krumholz,et al. Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure: An Observational Study , 2005, Circulation.
[372] C. Bulpitt,et al. Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. , 2005, Diabetes care.
[373] P. Raskin,et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. , 2004, JAMA.
[374] J. Mustonen,et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. , 2004, The New England journal of medicine.
[375] Stephen J. Aldington,et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. , 2004, Archives of ophthalmology.
[376] S. Kahn,et al. Impact of Intra-Abdominal Fat and Age on Insulin Sensitivity and β-Cell Function , 2004 .
[377] Robert A Berenson,et al. Lost in Transition: Challenges and Opportunities for Improving the Quality of Transitional Care , 2004, Annals of Internal Medicine.
[378] 曲东锋. Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .
[379] Y. Abe,et al. Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. , 2004, Diabetes research and clinical practice.
[380] Hylton B Menz,et al. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. , 2004, Archives of physical medicine and rehabilitation.
[381] E. Rimon,et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. , 2003, Archives of internal medicine.
[382] T. Inoue,et al. Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure. , 2003, Clinical nephrology.
[383] Markolf Hanefeld,et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.
[384] Claudio Cobelli,et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. , 2003, Diabetes.
[385] C. Bulpitt,et al. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. , 2003, Diabetes care.
[386] Quan Dong Nguyen,et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.
[387] A. Monsch,et al. Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women. , 2003, Age and ageing.
[388] D. Eckland,et al. The pharmacokinetics of pioglitazone in patients with impaired renal function. , 2003, British journal of clinical pharmacology.
[389] Ann K. Miller,et al. Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency , 2003, Journal of clinical pharmacology.
[390] S. Studenski,et al. Physical Performance Measures in the Clinical Setting , 2003, Journal of the American Geriatrics Society.
[391] C. Hasslacher. Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. , 2003, Diabetes care.
[392] G. Gill,et al. Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology , 2003 .
[393] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[394] Pamela J Schreiner,et al. Older women with diabetes have a higher risk of falls: a prospective study. , 2002, Diabetes care.
[395] Peter Mansell. Diabetes and driving , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[396] Gary C. Brown,et al. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. , 2002, Archives of ophthalmology.
[397] M. Franz,et al. The evidence for the effectiveness of medical nutrition therapy in diabetes management. , 2002, Diabetes care.
[398] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[399] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[400] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[401] A. Folsom,et al. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. , 2001, Diabetes care.
[402] G. McVeigh,et al. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. , 2001, Clinical science.
[403] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[404] C. Sueta,et al. Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. , 2001, The American journal of cardiology.
[405] Stephen J. Aldington,et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.
[406] R. Horswell,et al. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. , 2000, Diabetes care.
[407] G. Bakris,et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[408] F Prince,et al. Evaluation of postural stability in elderly with diabetic neuropathy. , 2000, Diabetes care.
[409] S. Grundy,et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.
[410] L. Melton,et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. , 1999, Diabetes care.
[411] D. Smith,et al. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. , 1999, Diabetes care.
[412] D G Smith,et al. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. , 1999, Diabetes care.
[413] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[414] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[415] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[416] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[417] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[418] Y. Friedlander,et al. Hypoglycemia in Hospitalized Nondiabetic Older Patients , 1998, Journal of the American Geriatrics Society.
[419] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[420] R. Schrier,et al. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[421] A. Sjølie,et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.
[422] H Lanshammar,et al. Gait Abnormalities in Diabetic Neuropathy , 1997, Diabetes Care.
[423] P. Thomas,et al. Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.
[424] W. Ray,et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, Archives of internal medicine.
[425] A. Adler,et al. Risk Factors for Diabetic Peripheral Sensory Neuropathy: Results of the Seattle Prospective Diabetic Foot Study , 1997, Diabetes Care.
[426] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[427] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[428] D. Dills,et al. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[429] Diana Dills1,et al. Clinical Evaluation of Glimepiride versus Glyburide in NIDDM in a Double-Blind Comparative Study , 1996 .
[430] W. Ray,et al. Individual Sulfonylureas and Serious Hypoglycemia in Older People , 1996, Journal of the American Geriatrics Society.
[431] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[432] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[433] A. Reuser,et al. An evaluation of the potential side‐effects of α‐glucosidase inhibitors used for the management of diabetes mellitus , 1994, European journal of clinical investigation.
[434] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[435] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[436] W. J. Litchy,et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.
[437] R. Lindeman. Changes in Renal Function with Aging , 1992 .
[438] J. Derr,et al. Problems with Gait and Posture in Neuropathic Patients with Insulin‐Dependent Diabetes Mellitus , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[439] W. Applegate,et al. Instruments for the functional assessment of older patients. , 1990, The New England journal of medicine.
[440] R. Kreisberg,et al. Cholesterol metabolism and aging. , 1987, The American journal of medicine.
[441] U S Nayak,et al. Balance in elderly patients: the "get-up and go" test. , 1986, Archives of physical medicine and rehabilitation.
[442] W. Duckworth,et al. The renal metabolism of insulin , 1984, Diabetologia.
[443] R E P O R T F R O M T H E A M E R I C A N D I A B E T E ,et al. American Diabetes Association , 1978, Diabetes.
[444] L. Balant,et al. Pharmacokinetics of glipizide in man: Influence of renal insufficiency , 1973, Diabetologia.
[445] C. Pieper,et al. Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications , 2018, The Journal of clinical endocrinology and metabolism.
[446] A. Sinclair,et al. An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017 , 2017, The Journal of Frailty & Aging.
[447] T. Bailey,et al. Comparison of Insulin Glargine 300 U / mL and 100 U / mL in Adults With Type 1 Diabetes : Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections , 2017 .
[448] M. Ruzicka,et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2017, The New England journal of medicine.
[449] N. Watts,et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. , 2016, The Journal of clinical endocrinology and metabolism.
[450] P. Romano,et al. Amputation Risk in Patients with Diabetes Mellitus and Peripheral Artery Disease Using Statewide Data. , 2016, Annals of vascular surgery.
[451] N. Watts,et al. Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin. , 2016, The Journal of clinical endocrinology and metabolism.
[452] G. Biessels,et al. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. , 2015, The lancet. Diabetes & endocrinology.
[453] Simeon I. Taylor,et al. Possible adverse effects of SGLT2 inhibitors on bone. , 2015, The lancet. Diabetes & endocrinology.
[454] D. Friedman,et al. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. , 2015, Ophthalmology.
[455] C. Giorda,et al. Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature , 2014, Endocrine.
[456] M. Özkaya,et al. Action to Control Cardiovascular Risk in Diabetes , 2013 .
[457] P. P. Toth. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy , 2012 .
[458] R. Klein,et al. Diabetic retinopathy. , 2012, The New England journal of medicine.
[459] Jackson T. Wright,et al. Evidence-Based Guideline for the Management of High Blood Pressure in Adults , 2012 .
[460] Michael S. Hong,et al. Emerging national trends in the management and outcomes of lower extremity peripheral arterial disease. , 2011, Annals of Vascular Surgery.
[461] Bijan Forogh,et al. Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. , 2011, Journal of rehabilitation research and development.
[462] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[463] B. Dorner,et al. Practice paper of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. , 2010, Journal of the American Dietetic Association.
[464] B. Dorner,et al. Position of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. , 2010, Journal of the American Dietetic Association.
[465] J. Baeyens,et al. European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .
[466] S. Schinner. Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice , 2010 .
[467] S. Schinner. Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age , 2010 .
[468] T. Dorman. Intensive versus Conventional Glucose Control in Critically Ill Patients , 2010 .
[469] 40026386 Return Undeliverable,et al. Canadian Agency for Drugs and Technologies in Health , 2009 .
[470] H. Parving,et al. DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. , 2008 .
[471] J. E. Morley,et al. The I.A.N.A. task force on frailty assessment of older people in clinical practice , 2008, The journal of nutrition, health & aging.
[472] L. Kennedy,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .
[473] Jennifer J. Otten,et al. DRI, Dietary reference intakes : the essential guide to nutrient requirements , 2006 .
[474] H. Ginsberg,et al. Diabetic dyslipidemia. , 2006, Endocrinology and metabolism clinics of North America.
[475] T. Elasy,et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association: response to Nesto. , 2004, Diabetes care.
[476] A. Chang,et al. Aging and insulin secretion. , 2003, American journal of physiology. Endocrinology and metabolism.
[477] Lawrence A Leiter,et al. Acarbose in the treatment of elderly patients with type 2 diabetes. , 2003, Diabetes research and clinical practice.
[478] S. Grundy,et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. , 2003, Circulation.
[479] Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1995, Ophthalmology.
[480] H. Parving. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[481] E. Lakatta. Changes in cardiovascular function with aging. , 1990, European heart journal.